Michael A. Letavic
Pfizer Global Research and Development
Groton Laboratories
Eastern Point Road
Groton
USA
Name/email consistency: high
- Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors. Letavic, M.A., Barberia, J.T., Carty, T.J., Hardink, J.R., Liras, J., Lopresti-Morrow, L.L., Mitchell, P.G., Noe, M.C., Reeves, L.M., Snow, S.L., Stam, E.J., Sweeney, F.J., Vaughn, M.L., Yu, C.H. Bioorg. Med. Chem. Lett. (2003)
- Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitors. Letavic, M.A., Axt, M.Z., Barberia, J.T., Carty, T.J., Danley, D.E., Geoghegan, K.F., Halim, N.S., Hoth, L.R., Kamath, A.V., Laird, E.R., Lopresti-Morrow, L.L., McClure, K.F., Mitchell, P.G., Natarajan, V., Noe, M.C., Pandit, J., Reeves, L., Schulte, G.K., Snow, S.L., Sweeney, F.J., Tan, D.H., Yu, C.H. Bioorg. Med. Chem. Lett. (2002)
- Synthesis and activity of a novel class of tribasic macrocyclic antibiotics: the triamilides. Letavic, M.A., Bronk, B.S., Bertsche, C.D., Casavant, J.M., Cheng, H., Daniel, K.L., George, D.M., Hayashi, S.F., Kamicker, B.J., Kolosko, N.L., Norcia, L.J., Oberton, V.D., Rushing, M.A., Santoro, S.L. Bioorg. Med. Chem. Lett. (2002)